AT THE CUTTING-EDGE OF INNOVATION
Preserving the commitment and innovative spirit of our foundation, our goal is to contribute to the rationalization of health resources, to provide solutions to health professionals’ needs, and to watch over the quality of life of millions of people around the world.
We are leaders in pharmaceutical innovation of generic medicines. Our Pharmaceutical Innovation and Development Area (aka “INFA”) has developed and manufactured such innovative products as:
• Second-gen Omeprazole: smaller and with many different advantages.
• Duloxetine: innovative development in pellets with own synthesis raw material, marketed in Europe and the United States.